Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Triffin who wrote (10551)	11/12/1998 4:31:00 PM
From: Manfred	Respond to of 119973

GZTC will blow tomorrow GZTC + Advanced Cell Technology According to the 48 Hours media rep, tonight's broadcast will feature news reported in this AM's NY Times regarding Advanced Cell Technology's ground breaking work -with trans-species embryonic stem cells and its implications for the possibility of growing new organs and tissue. See full article below. Advanced Cell Technology's news this AM is expected to spark extensive ethical-legal and scientific debate. ACT's web site advancedcell.com lays out the scope and direction of their work. ACT is private- but looking thru its recent news Songwire was able to identify one public partner-though not directly involved in today's discovery -GZTC Genzyme Trangenics which is teaming with ACT to work on human protein from cloned transgenic cattle. Using Cloned Transgenic Cattle Date: October 7, 1997 Genzyme Transgenics Corporation (Nasdaq:GZTC) and Advanced Cell Technology, Inc., Worcester, Mass., today announced that they have reached an agreement to produce human therapeutic proteins in the milk of cloned transgenic cattle. The collaboration, worth at least $10 million, combines Genzyme Transgenics' capabilities in expressing human proteins in the milk of transgenic animals with Advanced Cell Technology's proprietary techniques for producing cloned bovine embryos. Advanced Cell Technology has filed for extensive patent rights related to its technology which includes novel methods for culturing types of bovine fetal fibroblast cells – a type of cell found in connective tissue. Several of its cows are currently pregnant with cloned transgenic calves. " Information taken from daytraders.org